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Abstract  The  surgical  management  of  ectopia  lentis  (EL)  in  Marfan  syndrome  (MFS)  represents
a challenge  to  the  ophthalmologist.  We  reviewed  the  literature  on  the  surgical  management
of ectopia  lentis  in  MFS  patients  from  the  classical  pars  plana  lensectomy  (PPL)  to  the  most
innovative  scleral-  and  iris-ﬁxated  intraocular  lens  (IOL)  surgical  techniques.  The  results  with
the innovative  approaches  have  been  satisfactory  but  with  a  relatively  short  follow-up  period
and several  complications  associated,  and  the  need  of  a  highly  experienced  and  skilled  surgeon.
We suggest  that  PPL  approach  with  postsurgical  aphakia  is  the  safest  surgical  approach  to
ectopia lentis  in  MFS  on  a  routinely  basis.
© 2015  Sociedad  Mexicana  de  Oftalmología.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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¿Cual  es  el  mejor  manejo  quirúgico  de  ectopia  lentis  en  síndrome  de  Marfan?
Resumen  El  manejo  quirúrgico  de  ectopia  lentis  en  Síndrome  de  Marfan  representa  un  reto
para el  oftalmólogo.  Realizamos  una  revisión  de  la  literatura  sobre  el  tratamiento  quirúrgico  de
ectopia lentis  en  pacientes  con  Síndrome  de  Marfan  incluyendo  el  manejo  clásico  con  lensec-
tomía pars  plana  y  afaquia  postquirúrgica  así  como  como  el  uso  de  lentes  intraoculares  ﬁjados
a iris  o  esclera.  Los  resultados  con  estos  últimos  han  sido  satisfactorios,  pero  con  un  periodo  de
seguimiento  corto  y  diferentes  complicaciones,  además  de  que  requieren  de  un  cirujano  con
gran experiencia.  Sugerimos  que  lensectomia  pars  plana  es  el  abordaje  quirúrgico  más  seguro
de ectopia  lentis  en  Síndrome  de  Marfan  en  la  práctica  diaria.
© 2015  Sociedad  Mexicana  de  Oftalmología.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).∗ Corresponding author at: Rocky Mountains Lions Eye Institute, Univer
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Marfan  syndrome  (MFS)  is  a  connective  tissue  inherited
isease  associated  with  a  decreased  life  expectancy.1--4 It
as  and  incidence  of  2--3  per  10,000  individuals  with  no  sex
redilection.1 It  was  ﬁrst  described  by  Antoine-Bernard  Mar-
an  in  1896.1 It  is  caused  by  a  mutation  in  FBN1  (15q21.1)
ene  and  is  inherited  in  an  autosomal  dominant  fashion.2,4
his  gene  is  involved  in  the  production  of  the  extracellu-
ar  matrixprotein  ﬁbrillin,  an  essential  glycoprotein  for  the
ormation  of  elastic  ﬁbers  in  connective  tissue.  It  affects
he  ocular,  skeletal  and  cardiovascular  systems  with  great
linical  variability.5--7 Aortic  dilatation  and  dissection  are
he  most  important  and  life  threatening  manifestations.8,9
he  diagnosis  is  based  on  clinical  ﬁndings  according  to  the
evised  Ghent  nosology  criteria  that  includes  EL  as  one  of  its
ajor  criteria.10,11 Ocular  involvement  in  MFS  is  very  com-
on  (>50%)  and  places  a  high  burden  on  patients  quality
f  life.10--13 Although  EL  is  the  most  common  ocular  mani-
estation,  other  ocular  abnormalities  can  be  found  such  as
at  cornea,  increased  axial  length  (>3D),  hypoplasia  of  the
iliary  muscle  or  the  iris,  retinal  detachment,  cataracts,
laucoma,  strabismus,  and  amblyopia.14--20
A  stepwise  approach  is  recommended  for  the  manage-
ent  of  EL.  At  ﬁrst,  when  the  visual  axis  is  not  compromised
y  the  border  of  the  dislocated  lens  causing  diplopia  or
isual  distortion,  a  conservatory  management  with  opti-
al  refraction  is  preferable.  However,  surgical  intervention
s  indicated  when  a  functional  best  corrected  visual  acu-
ty  is  not  achieved,  the  refractive  status  is  unstable
ecause  of  lens  mobility  or  posterior  dislocation,  or  if  ante-
ior  dislocation  causes  secondary  ocular  hypertension  and
isk  of  glaucomatous  damage  and/or  risk  of  endothelial
ompromise.20--22
The  surgical  management  of  EL  in  MFS  represents
 challenge  to  the  ophthalmologist.  Fibrillin  microﬁbrils
re  disrupted  and  fragmented  in  the  lens  capsule,  iris
nd  sclera,  making  the  eye  more  susceptible  to  surgical
omplications.23,24 For  many  years  the  preferable  surgical
pproach  to  manage  the  dislocated  lens  in  these  patients  has
een  standard  lensectomy  with  or  without  anterior  vitrec-
omy  as  well  as  pars  plana  vitrectomy  (PPV)  and  lensectomy
PPL)  with  postoperative  refractive  correction  including  the
se  of  aphakic  glasses  or  contact  lenses.  With  the  advent  of
mall-incision  cataract  surgery  and  better  IOLs  and  capsular
ension  ring  and  segments,  techniques  and  approaches  for
L  have  evolved  and  various  scleral-  and  iris-ﬁxated  surgi-
al  techniques  have  been  proposed.  However,  the  average
atient  follow-up  in  the  majority  of  these  published  articles
s  1  year  and  several  complications  using  these  proposed
echniques  have  been  found,  including  pupillary  block,  iris
apture,  lens  decentration,  and  retinal  detachment  with
xation  to  the  iris  and/or  sclera.25--30
We  considered  a  classical  surgical  approach  to  manage
ctopia  lentis  in  MFS  when  a  lensectomy  is  performed  either
hrough  pars  plana  (PPV)  or  through  a  limbal  approach
ith  postoperative  aphakia.  Follow-up  for  these  studies
ange  from  1.5  to  102  months,  with  low  incidence  of
omplications.31--39
In  the  pars  plana  approach  a  standard  vitrectomy  tech-
ique  is  used.  A  20G  or  23G  vitrectomy  caliber  can  be
sed  depending  on  surgeon’s  preference.  The  vitrector  is
sed  to  engage  the  lens  from  a  posterior  approach  remov-
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 second  instrument  from  the  opposite  port  to  stabilize
he  lens.  In  the  limbal  approach,  as  described  by  Plager38
nd  Neely,36 a  peripheral  corneal  stab  incision  is  made
or  an  infusion  cannula  to  maintain  the  anterior  chamber
hroughout  the  procedure.  A  second  anterior  limbal  inci-
ion  is  created  with  a  MVR  for  the  vitrector  insertion.  The
VR  blade  is  advanced  through  the  cornea  to  penetrate  the
eripheral  anterior  lens  capsule  creating  2--3  mm  slit.  The
apsulorhexis  can  also  be  created  using  the  vitrector  which
s  then  utilized  to  aspirate  the  lens  followed  by  removal  of
ost  of  the  posterior  and  anterior  capsule  and  a  limited
nterior  vitrectomy.40 These  techniques  minimize  pulling
orces  and  trauma  to  the  zonules  and  iris  and  the  vitreous
ase.
Capsular  tension  rings  (CTRs)  have  provided  the  oppor-
unity  to  perform  small-incision  phacoemulsiﬁcation  and
n-the-bag  implantation  of  a  posterior  chamber  IOL  (PCIOL).
 capsular  tension  ring  functions  by  exerting  a centrifu-
al  force  at  the  capsular  equator,  expanding  the  capsular
ag  and  redistributing  tension  from  the  weakened  zonules
o  stronger,  intact  zonules.40 However,  the  capsular  tension
ing  cannot  provide  adequate  support  or  correct  decentra-
ion  of  the  capsular  bag  in  the  presence  of  extensive  zonular
ialysis.41 In  1998,  the  Cionni  modiﬁed  capsular  tension  ring
Morcher,  FCI  Ophthalmics,  Marshﬁeld  Hills,  MA,  USA)  was
ntroduced  to  help  manage  profound  zonular  weakness.42,43
he  Cionni  modiﬁed  capsular  tension  ring  can  be  ﬁxated  to
he  sclera  without  compromising  capsular  bag  integrity  with
 or  2  sutures.  In  2002,  Ahmed  designed  the  capsular  ten-
ion  segment  (Morcher,  FCI  Ophthalmics,  Marshﬁeld  Hills,
A,  USA),  of  120  degrees;  it  has  an  anteriorly  positioned  eye-
et,  which  enables  scleral  suture  ﬁxation.  Compared  to  the
ionni  modiﬁed  capsular  tension  ring,  the  capsular  tension
egment  can  be  inserted  into  the  capsule  bag  with  greater
ase  and  less  trauma  because  a  dialing  technique  is  not
ecessary.40 Bahar  reported  a  series  of  intraoperative  limita-
ions  difﬁculties  using  the  Cionni  ring  during  the  creation  of
 central  capsulorhexis  in  an  unstable  lens  as  well  as  during
he  implantation  of  the  cionni  ring  with  extensive  subluxa-
ion,  as  it  may  be  too  large  for  the  capsular  bag,  increasing
he  risk  of  a bag  tear.44
Another  option  is  an  iris-ﬁxated  IOL.  The  iris-ﬁxated
OL  could  be  implanted  in  the  posterior  or  the  anterior
hamber.  Brieﬂy,  in  the  iris-ﬁxated  PCIOL  a  three-piece
oldable  PCIOLs  is  inserted  with  the  haptics  placed  under
he  iris  and  the  optic  captured  in  the  pupil.  The  haptics
re  sutured  to  the  iris  with  a  curved  needle,  as  previously
escribed.28,45 For  the  iris-claw,  the  anterior  chamber  IOL
ACIOL)  is  introduced  with  the  haptics  at  3  and  9  o’clock  cen-
ered  on  the  pupil  and  an  enclavation  needle  is  used  to  ﬁxate
he  IOL  at  the  iris  midperiphery.28,46,47 The  incidence  of
omplications  reported  varies  within  the  series.  In  a  series  of
ases  reported  by  Hirashima,28 33.3%  of  the  patients  treated
ith  ACIOL  developed  iris  atrophy  at  the  enclavation  site,
nd  among  the  patients  treated  with  PCIOL,  31.25%  devel-
ped  iris  atrophy,  12.5%  had  a  retinal  detachment  and  18.7%
ad  IOL  decentration.  These  complications  were  reported
ith  a follow  up  of  only  12  months.  Also,  the  ACIOL  may
ccelerate  the  endothelial  cell  count  lose  and  potentially
ead  to  bullous  keratopathy.48--50 Another  concern  when  uti-
izing  an  ACIOL  is  the  potential  damage  to  the  trabecular





















3Best  surgical  approach  for  ectopia  lentis  in  Marfan  syndrome
Lastly,  different  alternatives  have  been  presented  for
placement  of  scleral-sutured  PC  lenses.  They  can  be  sutured
from  the  inside  out  (ab  interno)  or  by  passing  the  needles
from  the  outside  of  the  eye  inward  (ab  externo),  how-
ever  scleral-ﬁxated  IOLs  have  been  associated  with  several
complications  such  as  retinal  detachment  and  late  suture
breakage.53
Given  the  ﬁbrillin  deﬁciency  in  the  iris  and  sclera  as
well  as  anatomical  eye  abnormalities  in  Marfan  syndrome,
extreme  precaution  is  advised  with  IOL  implantation  and
scleral  ﬁxation.  The  scleral  and  iris  ﬁxated  IOL  techniques
are  very  skill  demanding  and  time  consuming  and  they
need  to  be  performed  by  a  very  experienced  surgeon.  Also,
long-term  prospective  or  randomized  studies  are  needed  to
determine  the  efﬁcacy  of  ACIOL  in  Marfan  syndrome.  With
these  questions  remaining  unanswered,  and  the  potential
complications  related  to  surgical  stress  to  zonules,  iris,  and
the  vitreous  base  we  conclude  that  the  classical  PPV  or
PPL  approach  with  postsurgical  aphakia  is  the  safest  sur-
gical  approach  to  ectopia  lentis  in  MFS  with  postoperative
correction  with  contact  lenses  or  glasses.
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